Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
K. Pafili & N. Papanas. (2019) Sodium-glucose cotransporter-2 inhibitors in type 2 diabetes: a magic potion to reduce heart failure?. Expert Review of Clinical Pharmacology 12:8, pages 693-695.
Read now
Read now
Kalliopi Pafili, Efstratios Maltezos & Nikolaos Papanas. (2017) Dapagliflozin for the treatment of type 1 diabetes mellitus. Expert Opinion on Investigational Drugs 26:7, pages 873-881.
Read now
Read now
Kalliopi Pafili, Efstratios Maltezos & Nikolaos Papanas. (2016) Pharmacokinetic and pharmacodynamic drug evaluation of tofogliflozin for the treatment of type 2 diabetes. Expert Opinion on Drug Metabolism & Toxicology 12:11, pages 1367-1380.
Read now
Read now
K. Pafili, E. Maltezos & N. Papanas. (2016) The potential of SGLT2 inhibitors in phase II clinical development for treating type 2 diabetes. Expert Opinion on Investigational Drugs 25:10, pages 1133-1152.
Read now
Read now
Articles from other publishers (7)
Zhenwang Zhang, Ping Ni, Mingqiu Tang, Yi Song, Chao Liu & Baoqing Zhao. (2023) Dapagliflozin alleviates renal podocyte pyroptosis via regulation of the HO‑1/NLRP3 axis. Molecular Medicine Reports 28:5.
Crossref
Crossref
Theocharis Koufakis, Nikolaos Papanas, George Dimitriadis, Pantelis Zebekakis & Kalliopi Kotsa. (2020)
Interpreting the results of the
VERTIS‐CV
trial: Is this the end of the “class effect” perspective?
. Journal of Diabetes 12:12, pages 942-945.
Crossref
Crossref
Fengjuan Huang, Yanyan Zhao, Qingzhu Wang, Jan-Luuk Hillebrands, Jacob van den Born, Linlin Ji, Tingting An & Guijun Qin. (2019) Dapagliflozin Attenuates Renal Tubulointerstitial Fibrosis Associated With Type 1 Diabetes by Regulating STAT1/TGFβ1 Signaling. Frontiers in Endocrinology 10.
Crossref
Crossref
Erica LW. Lester, Raj Padwal, Sumit R. Majumdar, F Ye, Daniel W. Birch & Scott W. Klarenbach. (2017) Association of Preference-Based Health-Related Quality of Life with Weight Loss in Obese Adults. Value in Health 20:4, pages 694-698.
Crossref
Crossref
Tushar Madaan, Mohd. Akhtar & Abul Kalam Najmi. (2016) Sodium glucose CoTransporter 2 (SGLT2) inhibitors: Current status and future perspective. European Journal of Pharmaceutical Sciences 93, pages 244-252.
Crossref
Crossref
Athanasia Papazafiropoulou, Nikolaos Papanas, Stavros Pappas, Efstratios Maltezos & Dimitri P. Mikhailidis. (2015) Effects of oral hypoglycemic agents on platelet function. Journal of Diabetes and its Complications 29:6, pages 846-851.
Crossref
Crossref
Ilias Migdalis, David Leslie, Anastasia Mavrogiannaki, Nikolaos Papanas, Paul Valensi & Helen Vlassara. (2015) Diabetes Mellitus 2014. International Journal of Endocrinology 2015, pages 1-4.
Crossref
Crossref